Higham CE, Johannsson G, Shalet SM, Hypopituitarism. Lancet. 2016;388(10058):2403–15. https://doi.org/10.1016/S0140-6736(16)30053-8.

Regal M, Páramo C, Sierra SM, Garcia-Mayor RV. Prevalence and incidence of hypopituitarism in an adult caucasian population in northwestern Spain. Clin Endocrinol (Oxf). 2001;55(6):735–40. https://doi.org/10.1046/j.1365-2265.2001.01406.x.

Article  PubMed  CAS  Google Scholar 

Fernández-Pérez L, Guerra B, Díaz-Chico JC, Flores-Morales A. Estrogens regulate the hepatic effects of growth hormone, a hormonal interplay with multiple fates. Front Endocrinol. 2013;4:66. https://doi.org/10.3389/fendo.2013.00066.

Article  Google Scholar 

Rosén T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 1990;336(8710):285–8. https://doi.org/10.1016/0140-6736(90)91812-o.

Article  PubMed  Google Scholar 

Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, et al. Association between premature mortality and hypopituitarism. West Midlands prospective Hypopituitary Study Group. Lancet. 2001;357(9254):425–31. https://doi.org/10.1016/s0140-6736(00)04006-x.

Article  PubMed  CAS  Google Scholar 

Olsson DS, Bryngelsson IL, Ragnarsson O. Higher incidence of morbidity in women than men with non-functioning pituitary adenoma: a Swedish nationwide study. Eur J Endocrinol. 2016;175(1):55–61. https://doi.org/10.1530/EJE-16-0173.

Article  PubMed  CAS  Google Scholar 

Sherlock M, Ayuk J, Tomlinson JW, Toogood AA, Aragon-Alonso A, Sheppard MC, et al. Mortality in patients with pituitary disease. Endocr Rev. 2010;31(3):301–42. https://doi.org/10.1210/er.2009-0033.

Article  PubMed  Google Scholar 

O’Sullivan EP, Woods C, Glynn N, Behan LA, Crowley R, O’Kelly P, et al. The natural history of surgically treated but radiotherapy-naïve nonfunctioning pituitary adenomas. Clin Endocrinol (Oxf). 2009;71(5):709–14. https://doi.org/10.1111/j.1365-2265.2009.03583.x.

Article  PubMed  Google Scholar 

Sherlock M, Toogood AA. Sensitivity of anterior pituitary hormones to irradiation. Expert Rev Endocrinol Metab. 2006;1(5):633–49. https://doi.org/10.1586/17446651.1.5.633.

Article  PubMed  CAS  Google Scholar 

Alexandraki KI, Grossman A. Management of Hypopituitarism. J Clin Med. 2019;8(12). https://doi.org/10.3390/jcm8122153.

Thompson CJ, Costello RW, Crowley RK. Management of hypothalamic disease in patients with craniopharyngioma. Clin Endocrinol (Oxf). 2019;90(4):506–16. https://doi.org/10.1111/cen.13929.

Article  PubMed  Google Scholar 

Mc Donald D, Crowley RK. Potential pitfalls in diagnosis of immunotherapy-induced hypothalamic-pituitary-adrenal axis suppression. Endocr Oncol. 2022;2(1):L1–3. https://doi.org/10.1530/EO-22-0069.

Article  PubMed  PubMed Central  Google Scholar 

Agha A, Rogers B, Sherlock M, O’Kelly P, Tormey W, Phillips J, et al. Anterior pituitary dysfunction in survivors of traumatic brain injury. J Clin Endocrinol Metab. 2004;89(10):4929–36. https://doi.org/10.1210/jc.2004-0511.

Article  PubMed  CAS  Google Scholar 

Hannon MJ, Behan LA, O’Brien MM, Tormey W, Javadpour M, Sherlock M, et al. Chronic hypopituitarism is uncommon in survivors of aneurysmal subarachnoid haemorrhage. Clin Endocrinol (Oxf). 2015;82(1):115–21. https://doi.org/10.1111/cen.12533.

Article  PubMed  CAS  Google Scholar 

Hannon MJ, Sherlock M, Thompson CJ. Pituitary dysfunction following traumatic brain injury or subarachnoid haemorrhage - in Endocrine Management in the Intensive Care Unit. Best Pract Res Clin Endocrinol Metab. 2011;25(5):783–98. https://doi.org/10.1016/j.beem.2011.06.001.

Article  PubMed  CAS  Google Scholar 

de Vries F, Bruin M, Lobatto DJ, Dekkers OM, Schoones JW, van Furth WR, et al. Opioids and their endocrine effects: a systematic review and Meta-analysis. J Clin Endocrinol Metab. 2020;105(3):1020–9. https://doi.org/10.1210/clinem/dgz022.

Article  PubMed  Google Scholar 

Silveira LF, Latronico AC. Approach to the patient with hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2013;98(5):1781–8. https://doi.org/10.1210/jc.2012-3550.

Article  PubMed  CAS  Google Scholar 

Faje A. Immunotherapy and hypophysitis: clinical presentation, treatment, and biologic insights. Pituitary. 2016;19(1):82–92. https://doi.org/10.1007/s11102-015-0671-4.

Article  PubMed  CAS  Google Scholar 

Boehm U, Bouloux PM, Dattani MT, de Roux N, Dodé C, Dunkel L, et al. Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism–pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2015;11(9):547–64. https://doi.org/10.1038/nrendo.2015.112.

Article  PubMed  Google Scholar 

Ilovayskaya I, Zektser V, Lazebnik L. Similarity of female central (hypogonadotropic) hypogonadism and postmenopause. Climacteric. 2017;20(4):356–61. https://doi.org/10.1080/13697137.2017.1315086.

Article  PubMed  CAS  Google Scholar 

Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R, et al. Hormonal replacement in hypopituitarism in adults: an endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101(11):3888–921. https://doi.org/10.1210/jc.2016-2118.

Article  PubMed  CAS  Google Scholar 

Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, et al. Testosterone therapy in men with hypogonadism: an endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715–44. https://doi.org/10.1210/jc.2018-00229.

Article  PubMed  Google Scholar 

Mitchell AL, Dwyer A, Pitteloud N, Quinton R. Genetic basis and variable phenotypic expression of Kallmann syndrome: towards a unifying theory. Trends Endocrinol Metab. 2011;22(7):249–58. https://doi.org/10.1016/j.tem.2011.03.002.

Article  PubMed  CAS  Google Scholar 

Seminara SB, Hayes FJ, Crowley WF Jr. Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann’s syndrome): pathophysiological and genetic considerations. Endocr Rev. 1998;19(5):521–39. https://doi.org/10.1210/edrv.19.5.0344.

Article  PubMed  CAS  Google Scholar 

Hamoda H, Panay N, Pedder H, Arya R, Savvas M. The British Menopause Society & Women’s Health concern 2020 recommendations on hormone replacement therapy in menopausal women. Post Reprod Health. 2020;26(4):181–209. https://doi.org/10.1177/2053369120957514.

Article  PubMed  Google Scholar 

Scarabin PY, Oger E, Plu-Bureau G. Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet. 2003;362(9382):428–32. https://doi.org/10.1016/S0140-6736(03)14066-4.

Article  PubMed  CAS  Google Scholar 

Løkkegaard E, Andreasen AH, Jacobsen RK, Nielsen LH, Agger C, Lidegaard Ø. Hormone therapy and risk of myocardial infarction: a national register study. Eur Heart J. 2008;29(21):2660–8. https://doi.org/10.1093/eurheartj/ehn408.

Article  PubMed  Google Scholar 

Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ. 2019;364:k4810. https://doi.org/10.1136/bmj.k4810.

Article  PubMed  PubMed Central  Google Scholar 

Canonico M, Carcaillon L, Plu-Bureau G, Oger E, Singh-Manoux A, Tubert-Bitter P, et al. Postmenopausal hormone therapy and risk of stroke: impact of the Route of Estrogen Administration and Type of Progestogen. Stroke. 2016;47(7):1734–41. https://doi.org/10.1161/STROKEAHA.116.013052.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Birzniece V, Ho KKY. Patching up a better pill for GH-deficient women. Nat Reviews Endocrinol. 2012;8(4):197–8. https://doi.org/10.1038/nrendo.2012.9.

Article  CAS  Google Scholar 

Mah PM, Webster J, Jonsson P, Feldt-Rasmussen U, Koltowska-Haggstrom M, Ross RJ. Estrogen replacement in women of fertile years with hypopituitarism. J Clin Endocrinol Metab. 2005;90(11):5964–9. https://doi.org/10.1210/jc.2005-1207.